eMolecules Newark Revenue

Biotechnology Research • Newark, Delaware, United States • 21-50 Employees

eMolecules Newark revenue & valuation

Annual revenue	$10,200,000
Revenue per employee	$222,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$32,700,000
Total funding	No funding

Key Contacts at eMolecules Newark

Tanner Watkins

Vp-Controller, Director Of Finance

Shane Hafycz

Director Of Software And Platform Engineering

Michelle Galante

Senior Director Of Operations

Company overview

Headquarters	601 Interchange Blvd, Newark, DE 19711, US
Phone number	+13022666891
Websites	emolecules.com frontierscientific.com frontiersci.com
Founded	1988
Employees	21-50
Socials

eMolecules Newark Email Formats

eMolecules Newark uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@emolecules.com), used 89.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@emolecules.com	89.5%
{first initial}.{last name}	j.doe@emolecules.com	10.5%

About eMolecules Newark

eMolecules is a leading chemical search-and-fulfillment platform that aims to reduce timelines in early drug discovery. Founded in 2005 and headquartered in San Diego, eMolecules provides scientists with access to over 83 million specialty chemistry and biology part numbers through its state-of-the-art digital platform. Our core offerings include: 1. A vast chemical structure database for building blocks and screening compounds 2. Integrated software for streamlined procurement 3. Compound reformatting, storage, and management services 4. Analytical chemistry and global distribution logistics 5. Synthesis of hits discovered from our multiple billion compound virtual libraries. eMolecules' platform -designed by chemists for chemists- offers real-time pricing, availability, and shipping information, and has strategic partnerships with major eProcurement and eCommerce platforms. Our mission is to accelerate drug discovery by removing inefficiencies in chemical compound sourcing. eMolecules serves pharmaceutical, biotechnology, academic, CRO, and agrochemical industries, providing essential tools and services to empower researchers in their quest for new cures and treatments. The site location in Newark (USA), is founded as Frontier Scientific Inc. in 1988, and provides chemistry and chemistry support services required in traditional small molecule drug discovery. eMolecules acquired Frontier Scientific Inc. (FSI) in September 2022.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Director

Employees by Department

eMolecules Newark has 19 employees across 8 departments.

Departments

Number of employees

Funding Data

eMolecules Newark has never raised funding before.

eMolecules Newark Tech Stack

Discover the technologies and tools that power eMolecules Newark's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Amazon Web Services

PaaS

Amazon ALB

Load balancers

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

PHP

Programming languages

HSTS

Security

AngularJS

JavaScript frameworks

Bootstrap

UI frameworks

Cart Functionality

Ecommerce

jQuery UI

JavaScript libraries

Google Analytics

Analytics

Frequently asked questions

eMolecules Newark is located in Newark, Delaware, US.

You can reach eMolecules Newark at +13022666891.

eMolecules Newark generates an estimated annual revenue of $10,200,000. This revenue figure reflects the company's market position and business performance in its industry.

eMolecules Newark has an estimated valuation of $32,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

eMolecules Newark was founded in 1988, making it 38 years old. The company has established itself as a significant player in its industry over this time.

eMolecules Newark has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.